Distinct antibody and memory B cell responses in SARS-CoV-2 naïve and recovered individuals after mRNA vaccination

Goel, Rishi R., Apostolidis, Sokratis A., Painter, Mark M., Mathew, Divij, Pattekar, Ajinkya, Kuthuru, Oliva, Gouma, Sigrid, Hicks, Philip +23 more·2021·Science Immunology
DOI 10.1126/sciimmunol.abi6950

Cited by (641)

Items 401–500 of 641

  1. Long-Term Dynamic Changes in Hybrid Immunity over Six Months after Inactivated and Adenoviral Vector Vaccination in Individuals with Previous SARS-CoV-2 Infection
    Nungruthai Suntronwong, Sitthichai Kanokudom, Chompoonut Auphimai, Thanunrat Thongmee, Suvichada Assawakosri, Preeyaporn Vichaiwattana, Ritthideach Yorsaeng, Thaneeya Duangchinda, Warangkana Chantima, Pattarakul Pakchotanon et al. · 2024 · Vaccines
  2. Evaluación de la respuesta de los anticuerpos IGG específicos contra SARS-CoV-2 en el personal de salud con el esquema completo de la vacuna Sputnik V (Gam-COVID-Vac)
    Ezequiel Córdova, María Inés Lespada, Diego M. Cecchini, Fabiola Nieto, Susana Palonsky, Mariana Badran, Silvina Virginia Bernasconi, Brenda Bacelar, Laura Morganti, F. Garibaldi et al. · 2022 · Vacunas
  3. Impact of Prior Infection on SARS-CoV-2 Antibody Responses in Vaccinated Long-Term Care Facility Staff
    Emily N. Gallichotte, Mary Nehring, Sophia Stromberg, Michael C Young, Ashley Snell, Josh Daniels, Kristy L. Pabilonia, Sue VandeWoude, Nicole P. Ehrhart, Gregory D. Ebel · 2022 · mSphere
  4. Differences in B-Cell Immunophenotypes and Neutralizing Antibodies Against SARS-CoV-2 After Administration of BNT162b2 (Pfizer-BioNTech) Vaccine in Individuals with and without Prior COVID-19 - A Prospective Cohort Study
    José Javier Morales‐Núñez, Mariel García‐Chagollán, José Francisco Muñóz-Valle, Saúl Alberto Díaz-Pérez, Paola Carolina Torres-Hernández, Saraí Citlalic Rodríguez-Reyes, Guillermo Santoscoy‐Ascencio, José Julio Sierra García de Quevedo, Jorge Hernández‐Bello · 2022 · Journal of Inflammation Research
  5. Flow cytometric assay for the detection of anti-SARS-CoV-2 Spike protein antibodies in serum of vaccinated volunteers
    Ekaterina A. Astakhova, Maria G. Byazrova, Saveliy Milyaev, Maria M. Sukhova, Artem A. Mikhailov, Aleksandr Morozov, Alexei G. Prilipov, Alexander V. Filatov · 2022 · Immunologiya
  6. Seroepidemiological and genomic investigation of SARS-CoV-2 spread in North East region of India
    Wahengbam Romi, Pankaj Bharali, Prasenjit Manna, Tridip Phukan, Moirangthem Goutam Singh, Gayatri Gogoi, Yasmin Begam Tapadar, Anil Kumar Singh, Rituraj Konwar, Channakeshavaiah Chikkaputtaiah et al. · 2022 · Indian Journal of Medical Microbiology
  7. Immune response and protective efficacy of the SARS-CoV-2 recombinant spike protein vaccine S-268019-b in mice
    Tomoyuki Homma, Noriyo Nagata, Masayuki Hashimoto, Naoko Iwata‐Yoshikawa, Naomi M. Seki, Nozomi Shiwa-Sudo, Akira Ainai, Keiji Dohi, Eiji Nikaido, Akiko Mukai et al. · 2022 · Scientific Reports
  8. Pre-clinical models to define correlates of protection for SARS-CoV-2
    Caolann Brady, Tom Tipton, Stéphanie Longet, Miles W. Carroll · 2023 · Frontiers in Immunology
  9. CD8 + T-cell memory induced by successive SARS-CoV-2 mRNA vaccinations is characterized by clonal replacement
    Hiroyasu Aoki, Masahiro Kitabatake, Haruka Abe, Peng Xu, Mikiya Tsunoda, Shigeyuki Shichino, Atsushi Hara, Noriko Ouji-Sageshima, Chihiro Motozono, Toshihiro Ito et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  10. A SARS-CoV-2 vaccine on an NIR-II/SWIR emitting nanoparticle platform
    Ying-Ying Jiang, M. Sanyal, Noor A. Hussein, Ani Baghdasaryan, Mengzhen Zhang, Fei-Fei Wang, Fuqiang Ren, Jiachen Li, Guan-Zhou Zhu, Yifan Meng et al. · 2025 · Science Advances
  11. A consensus mathematical model of vaccine-induced antibody dynamics for multiple vaccine platforms and pathogens
    Kristen M. Wilding, Carmen Molina-Parı́s, Jessica Z. Kubicek-Sutherland, Benjamin H. McMahon, Alan S. Perelson, Ruy Miguel Ribeiro · 2025 · Frontiers in Immunology
  12. Humoral and Memory B Cell Responses Following SARS-CoV-2 Infection and mRNA Vaccination
    Martina Bozhkova, Ralitsa Raycheva, Steliyan Petrov, Dobrina Dudova, Teodora Kalfova, Marianna Murdjeva, Hristo B. Taskov, Velizar Stefanov Shivarov · 2025 · Vaccines
  13. Boosting corrects a memory B cell defect in SARS-CoV-2 mRNA–vaccinated patients with inflammatory bowel disease
    Kathryn A. Pape, Thamotharampillai Dileepan, William E. Matchett, Charles Ellwood, Samuel Stresemann, Amanda J. Kabage, Daria Kozysa, Clayton Evert, Michael Matson, Sharon Lopez et al. · 2022 · JCI Insight
  14. Association between Reactogenicity and Immunogenicity in a Vaccinated Cohort with Two mRNA SARS-CoV-2 Vaccines at a High-Complexity Reference Hospital: A Post Hoc Analysis on Immunology Aspects of a Prospective Cohort Study
    Joaquín Sáez‐Peñataro, Gonzalo Calvo, Juan Bascuas, Maria Cecilia Mosquera, María Ángeles Marcos, Natalia Egri, Ferràn Torres · 2024 · Vaccines
  15. Intrinsic immunogenicity is a major determinant of type-specific responses in SARS-CoV-2 infections
    Grace Quirk, Marta V. Schoenle, Kameron L. Peyton, Jennifer L. Uhrlaub, Branden Lau, Chieh-Yu Liang, Jefferey L. Burgess, Katherine Ellingson, Shawn C. Beitel, James K. Romine et al. · 2025 · Nature Immunology
  16. Prolonged effects of adenoviral vector priming on T-cell cytokine production in heterologous adenoviral vector/mRNA COVID-19 vaccination regimens
    Masanori Isogawa, Taishi Onodera, Akira Ainai, Ryutaro Kotaki, Takayuki Kanno, Shinji Saito, Minoru Tobiume, Kenzo Tokunaga, Megumi Hara, Yoshio Hirota et al. · 2025 · Scientific Reports
  17. Pathogenic IgE-fated memory B cell responses retain functional plasticity
    Kelly M. Bruton, Allyssa Phelps, Atai Ariaz, Allison Fang, Tina D. Walker, Jianping Wen, Sharon S. Khavkine-Binstock, Danielle Della Libera, Olivia Mann-Delany, Niels Peter Hell Knudsen et al. · 2026 · Science Immunology
  18. Humoral anti-SARS-CoV-2 immune response after two doses of Comirnaty vaccine in nursing home residents by previous infection status
    François Helle, Julien Moyet, Baptiste Demey, Catherine François, Gilles Duverlie, Sandrine Castelain, Frédéric Bloch, Étienne Brochot · 2021 · Vaccine
  19. Kinetics and persistence of anti‐SARS‐CoV‐2 neutralisation and antibodies after BNT162b2 vaccination in a Swiss cohort
    Lara Šošić, Marta Paolucci, Agathe Duda, Fabio Hasler, Senta M. Walton, Thomas M. Kündig, Pål Johansen · 2021 · Immunity Inflammation and Disease
  20. COVID-19: Pathophysiology, Transmission, and Drug Development for Therapeutic Treatment and Vaccination Strategies
    Vishal Kumar Singh, Himani Chaurasia, Richa Mishra, Ritika Srivastava, Aditya K. Yadav, Jayati Dwivedi, Prashant Singh, Ramendra Kumar Singh · 2022 · Current Pharmaceutical Design
  21. COVID ‐19 vaccine humoral response in frequent platelet donors with plateletpheresis‐associated lymphopenia
    Annemarie Laumaea, Antoine Lewin, Debashree Chatterjee, Lorie Marchitto, Shilei Ding, Gabrielle Gendron‐Lepage, Guillaume Goyette, Marie-Eve Allard, Carl Simard, Tony Tremblay et al. · 2022 · Transfusion
  22. Coronavirus Vaccination: Spike Antibody Levels in Health Workers after Six Months—A Cross-Sectional Study
    Lukas Damerau, Georg Mühlenbruch, Agnes Evenschor-Ascheid, Christine Fussen, Albert Nienhaus, Claudia Terschüren, Robert Herold, Volker Harth · 2022 · International Journal of Environmental Research and Public Health
  23. Humoral and Cellular Immune Responses After a 3-dose Course of mRNA-1273 COVID-19 Vaccine in Kidney Transplant Recipients: A Prospective Cohort Study
    David Cucchiari, Natalia Egri, Diana Rodríguez‐Espinosa, Enrique Montagud‐Marrahí, Joaquim Casals, Jimena Del Risco-Zevallos, Marta Bodro, Pedro Ventura‐Aguiar, Frederic Cofán, Judit Cacho et al. · 2022 · Transplantation Direct
  24. Assessing T-Cell Immunity in Kidney Transplant Recipients with Absent Antibody Production after a 3rd Dose of the mRNA-1273 Vaccine
    Maria Giaele Infantino, Aris Tsalouchos, Edda Russo, Selene Laudicina, Valentina Grossi, Barbara Lari, Maurizio Benucci, Lorenzo Stacchini, Amedeo Amedei, Patrizia Casprini et al. · 2022 · International Journal of Molecular Sciences
  25. Donor selection for adoptive cell therapy with CD45RA− memory T cells for patients with coronavirus disease 2019, and dexamethasone and interleukin-15 effects on the phenotype, proliferation and interferon gamma release
    Karima Al‐Akioui‐Sanz, Bárbara Pascual-Miguel, Mariana Díaz‐Almirón, Carmen Mestre‐Durán, Alfonso Navarro‐Zapata, Laura Clares Villa, Carla Martín-Cortázar, José Luis Vicario, Miguel Ángel Moreno, A. Balas et al. · 2022 · Cytotherapy
  26. Vaccinomics: Paving the Way for Personalized Immunization
    Laith Naser AL-Eitan, Moh’d. Fahmi Munib ElMotasem, Iliya Yacoub Khair, Saif Zuhair Alahmad · 2023 · Current Pharmaceutical Design
  27. Identification of B cell subsets based on antigen receptor sequences using deep learning
    Hyunho Lee, Kyoungseob Shin, Yongju Lee, Soobin Lee, Seungyoun Lee, Eunjae Lee, S. Kim, H. Shin, Jong Hoon Kim, Jun-Ho Chung et al. · 2024 · bioRxiv
  28. Antigen-specific T helper cells and cytokine profiles predict intensity and longevity of cellular and humoral responses to SARS-CoV-2 booster vaccination
    Lukas Page, Kevin M. Dennehy, Katharina Mueller, Philipp Girl, Eva Loell, Hellen Buijze, Johanna-Maria Classen, Helmut Messmann, Christoph Römmele, Reinhard F. G. Hoffmann et al. · 2024 · Frontiers in Immunology
  29. Mechanistic models of humoral kinetics following COVID-19 vaccination
    Daniel Stocks, Amy C Thomas, Adam H.R. Finn, León Danon, Ellen Brooks‐Pollock · 2025 · Journal of The Royal Society Interface
  30. The comprehensive insights into the B-cells-mediated immune response against COVID-19 infection amid the ongoing evolution of SARS-CoV-2
    Manish K. Dhawan, Nanamika Thakur, Manish Kumar Sharma, Ali Ahmed Rabaan · 2025 · Biomedicine & Pharmacotherapy
  31. Neutralizing Antibodies Responses against SARS-CoV-2 in a Sardinian Cohort Group Up to 9 Months after BNT162b2 Vaccination
    Giuseppina Sanna, Alessandra Marongiu, Davide Firinu, Cristina Piras, Gianluigi Franci, Massimiliano Galdiero, Giuseppe Pala, Vanessa Palmas, Fabrizio Angius, Roberto Littera et al. · 2022 · Vaccines
  32. Evidence of premature lymphocyte aging in people with low anti-spike antibody levels after BNT162b2 vaccination
    Yapei Huang, Juliana E. Shin, Alexander M. Xu, Changfu Yao, Sandy Y. Joung, Min Wu, Ruan Zhang, Bongha Shin, Joslyn Foley, Simeon Mahov et al. · 2022 · iScience
  33. Mapping IgA Epitope and Cross-Reactivity between Severe Acute Respiratory Syndrome-Associated Coronavirus 2 and DENV
    Salvatore G. De-Simone, Paloma Napoleão-Pêgo, Guilherme Curty Lechuga, João P. R. S. Carvalho, Maria Eduarda dos Santos Monteiro, Carlos Medicis Morel, David William Provance · 2023 · Vaccines
  34. SARS-CoV-2 in Kidney Transplant Recipients: A Systematic Review
    Naveen Kumar, Rashmi Rana, Devinder Singh Rana, Anurag Gupta, MOHINDER PAL SACHDEVA · 2022 · Transplantology
  35. Convergent CDR3 homology amongst Spike-specific antibody responses in convalescent COVID-19 subjects receiving the BNT162b2 vaccine
    Matthew Wong, Jun T Liu, Patrick Budylowksi, Feng Yun Yue, Zhijie Li, James M. Rini, James R. Carlyle, Amin Zia, Mario Ostrowski, Alberto Martín · 2022 · Clinical Immunology
  36. Evaluation of Natural and Vaccine-Induced Anti-SARS-CoV-2 Immunity: A Comparative Study between Different Groups of Volunteers
    Maria Caterina Schipani, Flaminia Tomassetti, Isabella Polidori, Paola Ricci, Maria Loredana Frassanito, Silva Seraceni, Maria Morello, Eleonora Nicolai, Stefano Aquaro, Sergio Bernardini et al. · 2022 · Diseases
  37. Antibody response after first and second BNT162b2 vaccination to predict the need for subsequent injections in nursing home residents
    Édouard Tuaillon, Amandine Pisoni, Nicolas Veyrenche, Sophia Rafasse, Clémence Niel, Nathalie Gros, Delphine M. Muriaux, Marie‐Christine Picot, Safa Aouinti, Philippe Van de Perre et al. · 2022 · Scientific Reports
  38. Statistics of antibody binding to the spike protein explain the dependence of COVID 19 infection risk on antibody concentration and affinity
    David Edward Williams · 2022 · Scientific Reports
  39. Modeling and Predicting Antibody Durability for mRNA-1273 Vaccine for SARS-CoV-2 Variants
    George Luo, Zhongbo Hu, John J. Letterio · 2021 · medRxiv
  40. Advances in the structure-based design of protein vaccines for respiratory infectious diseases
    Xiaotian Tie, Jiaxuan Li, Hao Wu, Ruiqi Weng, Yanjun Zhang, Jianhua Li, Keda Chen · 2025 · Computational and Structural Biotechnology Journal
  41. Comparable safety and non-inferior immunogenicity of the SARS-CoV-2 mRNA vaccine candidate PTX-COVID19-B and BNT162b2 in a phase 2 randomized, observer-blinded study
    Lawrence Reiter, Johann Greffrath, Bian Zidel, Mario Ostrowski, Jennifer L. Gommerman, Shabir Ahmed Madhi, Richard Tran, Natalia Martín‐Orozco, Rajesh Krishnan Gopalakrishna Panicker, Curtis Cooper et al. · 2024 · Scientific Reports
  42. Limitations of neutralizing antibody titers in COVID-19 vaccine efficacy trials and a call for additional correlates of protection
    Young Hoon Hwang, Dal‐Hee Min, Wan Beom Park · 2025 · Human Vaccines & Immunotherapeutics
  43. Dysregulated inflammation in solid tumor malignancy patients shapes polyfunctional antibody responses to COVID-19 vaccination
    Ruth A Purcell, Marios Koutsakos, Łukasz Kedzierski, Lilith F. Allen, O. Williams, Jo-Wai Douglas Wang, George Cavic, Adam K. Wheatley, Wen Shi Lee, Bruce D. Wines et al. · 2025 · npj Vaccines
  44. Hybrid Immunity Overcomes Defective Immune Response to COVID-19 Vaccination in Kidney Transplant Recipients
    Nicolas Gemander, Delphine Kemlin, Stéphanie Depickère, Natasha S. Kelkar, Pieter Pannus, Shilpee Sharma, Alexandra Waegemans, Véronique Olislagers, Daphnée Georges, Emilie Dhondt et al. · 2023 · Kidney International Reports
  45. Relative deficiency in interferon‐γ‐secreting CD4+ T cells is strongly associated with poorer COVID‐19 vaccination responses in older adults
    Vanda Ho, Heng Boon Low, Jianzhou Cui, Zhou Juequn, Bhuvaneshwari D O Shunmuganathan, R. Gupta, Nikki Y.J. Tan, Xinlei Qian, Kiren Purushotorman, SCOPE Cohort Study Group et al. · 2024 · Aging Cell
  46. Using neural networks to autonomously assess adequacy in intraoperative cholangiograms
    Henry E. Badgery, Yuning Zhou, James Bailey, Peter Brotchie, Lynn Chong, Daniel Gerald Croagh, Mark Page, Catherine E. Davey, Matthew D. Read · 2024 · Surgical Endoscopy
  47. COVID-19 mRNA vaccination responses in individuals with sickle cell disease: an ASH RC Sickle Cell Research Network Study
    Alan Randall Anderson, John Joseph Strouse, Deepa G. Manwani, Amanda M. Brandow, Elliott P. Vichinsky, Andrew Campbell, Patrick J. Leavey, Alecia C. Nero, Ibrahim F. Ibrahim, Joshua J. Field et al. · 2024 · Blood Advances
  48. Mucosal and Serum Neutralization Immune Responses Elicited by COVID-19 mRNA Vaccination in Vaccinated and Breakthrough-Infection Individuals: A Longitudinal Study from Louisville Cohort
    Lalit Batra, Divyasha Saxena, Triparna Poddar, Maryam Zahin, Alok Ravindra Amraotkar, Megan M. Bezold, Kathleen T. Kitterman, Kailyn Deitz, Amanda B. Lasnik, Rachel J. Keith et al. · 2025 · Vaccines
  49. Single-cell RNA-seq analysis identifies distinct myeloid cells in a case with encephalitis temporally associated with COVID-19 vaccination
    Masakazu Ishikawa, Yuki Shimada, Tatsuhiko Ozono, Hisatake Matsumoto, Hiroshi Ogura, Keigo Kihara, Hideki Mochizuki, Tatsusada Okuno, Shuhei Sakakibara, Makoto Kinoshita et al. · 2023 · Frontiers in Immunology
  50. To be remembered: B cell memory response against SARS‐CoV ‐2 and its variants in vaccinated and unvaccinated individuals
    Nafees Ahmed, Atharv Athavale, Ankita Harishchandra Tripathi, Adarsh Subramaniam, Santosh Kumar Upadhyay, Anil Kumar Pandey, Ramesh Chandra Rai, Amit Awasthi · 2023 · Scandinavian Journal of Immunology
  51. Unravelling humoral immunity in SARS-CoV-2: Insights from infection and vaccination
    Nouhaila Najimi, Chaimae Kadi, Noureddine Elmtili, Fouad Seghrouchni, Youssef Bakri · 2024 · Human Antibodies
  52. Beyond neutralization for BNT162b2 mRNA vaccination
    Payal Damani‐Yokota, Stephen T. Yeung, Kamal Mohan Khanna · 2021 · Cell Host & Microbe
  53. Hyperacute optic neuritis in a patient with COVID-19 infection and vaccination: a case report
    Jessica Zhang, Devon B. Joiner, Cheng Zhang · 2023 · BMC Ophthalmology
  54. A Rapid Saliva Test for Monitoring Immune Protection against SARS -CoV-2 and its Variants
    Victoria S. A. Momyer, Samantha Dixon, Q. John Liu, Brian Wee, Tiffany Chen, A. E. Petropoulos, L. Jessica Sang · 2021 · medRxiv
  55. Poor immunogenicity upon SARS-CoV-2 mRNA vaccinations in autoimmune SLE patients is associated with pronounced EF-mediated responses and anti-BAFF/Belimumab treatment
    Caterina Elisa Faliti, Fabliha A. Anam, Narayanaiah Cheedarla, Matthew Charles Woodruff, Sabeena Y. Usman, Martin C. Runnstrom, Trinh T. P. Van, Shuya Y. Kyu, Hasan Ahmed, Andrea Morrison-Porter et al. · 2023 · medRxiv
  56. Profiling the broad antibody diversity of lymphatic filariasis immune antibody repertoire by deep sequencing
    Chia Chiu Lim, Theam Soon Lim · 2025 · International Journal of Biological Macromolecules
  57. mRNA Vaccines for Cancer Treatment
    Robert J. Torphy, Vinod Balachandran, Kevin C. Soares · 2026 · Surgical Oncology Clinics of North America
  58. B-Cell Responses to Sars-Cov-2 mRNA Vaccines
    Lela Kardava, Clarisa M. Buckner, Susan L. Moir · 2022 · Pathogens and Immunity
  59. Receptor-Binding-Domain-Specific B Cell Responses Induced by mRNA Immunization against SARS-CoV-2
    Maria Geropeppa, Ioanna Papadatou, Panagiotis Sarantis, Marianna Tzanoudaki, Ioannis Ntanasis‐Stathopoulos, Tina Bagratuni, Evangelos Terpos, Vana I. Spoulou · 2023 · Vaccines
  60. Immune response kinetics to SARS-CoV-2 infection and COVID-19 vaccination among nursing home residents—Georgia, October 2020–July 2022
    Zeshan Chisty, Deana D. Li, Melia Haile, Hollis Houston, Juliana C. DaSilva, Rahsaan Overton, Amy J. Schuh, Jenn Haynie, Jacob Clemente, Alicia Branch et al. · 2024 · PLoS ONE
  61. Variant-proof high affinity ACE2 antagonist limits SARS-CoV-2 replication in upper and lower airways
    Matthew Gagné, Barbara J. Flynn, Christopher Cole Honeycutt, Dillon R. Flebbe, Shayne F. Andrew, Samantha J. Provost, Lauren McCormick, Alex Van Ry, Elizabeth E. McCarthy, John-Paul M. Todd et al. · 2024 · Nature Communications
  62. Comparative analysis of cellular immune responses to four seasonal inactivated influenza vaccines in younger and older adults
    Vanessa Silva‐Moraes, Laise Rodrigues Reis, Ted M. Ross · 2025 · The Journal of Immunology
  63. Humoral immune response to SARS-CoV-2 mRNA vaccines is associated with choice of vaccine and systemic adverse reactions DMD TNR
    Hanna Klingel, Alexander Krüttgen, Matthias Imöhl, Michael Kleines · 2023 · Clinical and Experimental Vaccine Research
  64. Immune response to BNT162b2 SARS-CoV-2 vaccine in patients living with HIV: The COVIH-DAPT study
    Sabrina Manni, Caroline Ruetsch-Chelli, Roxane Fabre, Michel Ticchioni, Daisy Graça, Christian Pradier, Barbara Seitz‐Polski, Laurène Lotte, Vesna Brglez, Matteo Vassallo · 2023 · Frontiers in Immunology
  65. Salivary Antibody Responses to Two COVID-19 Vaccines following Different Vaccination Regimens
    Hassan Alkharaan, Hatem Alqarni, Muath Aldosari, Mohammed Alsaloum, Ghada Aldakheel, Mohammed W. Alenazi, Naif Khalaf Alharbi · 2023 · Vaccines
  66. Timing and implications for immune response to vaccine in SARS-CoV-2 breakthrough infections
    Stefania Arsuffi, Emanuele Sansone, Emanuele Focà, Samuele Storti, Teresa Diaferia, Carlo Bonfanti, Luigina Terlenghi, Arnaldo Caruso, Emma Sala, Francesco Castelli et al. · 2023 · iScience
  67. Expression Analysis of Interleukin-13 Gene in the Small Intestine of Three Genotypes of chickens Administered Conventional Antibiotics and Garlic
    2023 · International Journal of Veterinary Science
  68. Impact of B Cell Depletion on COVID-19 in Kidney Transplant Recipients
    Naohiro Aida, Taihei Ito, Kei Kurihara, Izumi Hiratsuka, Megumi Shibata, Atsushi Suzuki, Midori Hasegawa, Takashi Kenmochi · 2023 · Viruses
  69. Systems biology of B cells in COVID-19
    Matthew Charles Woodruff, Caterina Elisa Faliti, Igñacio Sanz · 2024 · Seminars in Immunology
  70. Elucidating the Immune Response to SARS-CoV-2: Natural Infection versus Covaxin/Covishield Vaccination in a South Indian Population
    Agalya Vanamudhu, Renuka Devi Arumugam, Arul Nancy, Nandhini Selvaraj, Kadar Moideen, Syed S Hissar, Uma Devi Ranganathan, Ramalingam Bethunaickan, Subash Babu, Nathella Pavan Kumar · 2024 · Viruses
  71. Persistent and robust antibody responses to ChAdOx1-S Oxford-AstraZeneca (ChAdOx1-S, Covishield) SARS-CoV-2 vaccine observed in Ugandans across varied baseline immune profiles
    Jennifer Serwanga, Gerald Kevin Oluka, Claire Baine, Violet Ankunda, Jackson Sembera, Laban Kato, Joseph Ssebwana Katende, Geoffrey Odoch, Betty Oliver Auma, Ben Gombe et al. · 2024 · PLoS ONE
  72. Influence of previous COVID-19 exposure and vaccine type (CoronaVac, ChAdOx1 nCov-19 or BNT162b2) on antibody and cytokine (Th1 or Th2) responses
    Diana Lourdes Padilla-Bórquez, Mónica Guadalupe Matuz-Flores, Jorge Hernández‐Bello, Jesús A. Rosas‐Rodríguez, Francisco Javier Turrubiates‐Hernández, Samuel García‐Arellano, Guillermo González-Estévez, Hazael Ramiro Ceja-Gálvez, Edith Oregon‐Romero, Alberto Gabriel López-Reyes et al. · 2024 · Human Vaccines & Immunotherapeutics
  73. Uninformative and unuseful: why it is necessary to actively challenge COVID-19 antibody testing postvaccination
    Daniel Romero-Álvarez, Daniel F. López‐Cevallos, Irene Torres · 2021 · Public Health
  74. Transcriptome and TCR Repertoire Measurements of CXCR3+ T Follicular Helper Cells Within HIV-Infected Human Lymph Nodes
    Chenfeng He, Michael J. Malone, Ben S. Wendel, Ke-Yue Ma, Daniel Del Alcazar, David B. Weiner, Philip L. De Jager, Perla M. Del Río Estrada, Yuria Ablanedo‐Terrazas, Gustavo Reyes‐Terán et al. · 2022 · Frontiers in Immunology
  75. Robust humoral and cellular immune responses in long-term convalescent COVID-19 individuals following one-dose SARS-CoV-2 inactivated vaccination
    Boyun Liang, Tiandan Xiang, Hua Wang, Ziwei Li, Xufeng Quan, Xuemei Feng, Sumeng Li, Sihong Lu, Lei Fan, Ling Xu et al. · 2022 · Frontiers in Immunology
  76. Immune responses to SARS-CoV-2 infection and COVID-19 vaccines
    Basista Rabina Sharma, Ravindra P. Veeranna · 2022 · Exploration of Immunology
  77. Neutralization against SARS-CoV-2 Delta/Omicron variants and B cell response after inactivated vaccination among COVID-19 convalescents
    Hao Wang, Yuan Yu, Bihao Wu, Mingzhong Xiao, Zhen Wang, Tingyue Diao, Rui Zeng, Li Chen, Yanshou Lei, Pinpin Long et al. · 2023 · Frontiers of Medicine
  78. Impact of Previous Common Human Coronavirus Exposure on SARS-CoV-2-Specific T-Cell and Memory B-Cell Response after mRNA-Based Vaccination
    José L. Casado, Pilar Vizcarra, Adrián Martín-Hondarza, Magdalena Blasco, Marta Grandal Platero, Johannes Häemmerle, Marina Fernández-Escribano, Alejandro Vallejo · 2023 · Viruses
  79. Natural heteroclitic-like peptides are generated by SARS-CoV-2 mutations
    Camilla Tiezzi, Andrea Lorenzo Vecchi, Marzia Rossi, Davide Cavazzini, Angelo Bolchi, Diletta Laccabue, Sara Doselli, Amalia Penna, Luca Sacchelli, Federica Brillo et al. · 2023 · iScience
  80. Significance of Anti-COVID-IgA antibody response in COVID-19 breakthrough infection in vaccinated patients – a single-centered study from Pakistan
    Sabiha Anis, Mariam Ashfaq Khan, Areej Fatima, Fatima Kanani, Javeria Aijaz, Aneela N. Hussain, Samreen Sarfaraz · 2023 · Immunologic Research
  81. Predictors of SARS-CoV-2 anti-Spike IgG antibody levels following two COVID-19 vaccine doses among children and adults in the Canadian CHILD Cohort
    Rilwan Azeez, Spencer R. Ames, Larisa C. Lotoski, Geoffrey L. Winsor, Corey R. Arnold, Yannick Galipeau, Martin Pelchat, Stephanie Goguen, Elinor Simons, Theo J. Moraes et al. · 2026 · Vaccine
  82. Seroprevalence of SARS-CoV-2 infection in the Tyrolean district of Schwaz at the time of the rapid mass vaccination in March 2021 following B.1.351-variant outbreak
    Peter Willeit, Janine Kimpel, Hannes Winner, Teresa Harthaller, Helena Schäfer, David Bante, Barbara Falkensammer, Annika Rössler, Lydia Riepler, Cornelia Ower et al. · 2022 · Frontiers in Public Health
  83. A Rare Case of BIA-ALCL Mass Associated with Mastectomy Skin Flap Erythema After Immunization with COVID-19
    Cristina Garusi, Eleonora De Antoni, Stefano Fiori, Anna Vanazzi, Stefano Aldo Pileri · 2022 · Aesthetic Plastic Surgery
  84. Declined Antibody Responses to COVID-19 mRNA Vaccine within First Three Months
    Paul Naaber, Liina Tserel, Kadri Kangro, Epp Sepp, Virge Jürjenson, Ainika Adamson, Liis Haljasmägi, Anna Pauliina Rumm, Regina Maruste, Jaanika Kärner et al. · 2021 · SSRN Electronic Journal
  85. PERFORMANCE AND UTILITY OF AN ORAL FLUID-BASED RAPID POINT-OF-CARE TEST FOR SARS-COV-2 ANTIBODY RESPONSE FOLLOWING COVID-19 INFECTION OR VACCINATION
    Paturi Vishnupriya Rao, Dhanalakshmi Nair-Shaef, Siting Chen, Steven C. Kazmierczak, Charles T. Roberts, Srinivasa R. Nagalla · 2021 · medRxiv
  86. Long-Term Dynamics of SARS-CoV-2 Variant-Specific Neutralizing Antibodies Following mRNA Vaccination and Infection
    Veronika Vaňová, Jana Náhliková, Martina Ličková, Monika Slavíková, Ivana Kajanová, Ľubomíra Lukáčiková, Miroslav Sabo, Žofia Rádiková, Silvia Pastoreková, Boris Klempa · 2025 · Viruses
  87. Lack of harmonisation in immunological data: challenges in synthesising data during the COVID-19 pandemic
    Nicole Shaver, Caroline Colijn, Jane Marie Heffernan, Gideon Darko Asamoah, Thomas Piggott, Curtis Cooper, Salman Bagheri, Angela M. Crawley, Benjamin M. N. Kagina, Dawn M. E. Bowdish et al. · 2026 · EBioMedicine
  88. Cross-direct effects in settings with two mediators
    Erin E. Gabriel, Arvid Sjölander, Dean A. Follmann, Michael Charles Sachs · 2022 · Biostatistics
  89. Neutralizing antibodies and T-cell responses to inactivated SARS-CoV-2 vaccine in COVID-19 convalescents one and a half years after infection
    Lina Yan, Dan Li, Zhendong Wang, Zezheng Jiang, Xiao Xiao, Xue‐jie Yu · 2022 · Virus Research
  90. Dynamics of humoral immune response in SARS-CoV-2 infected individuals with different clinical stages
    Yorjagis Andres Mendez Cortina, Ana Lucía Rodríguez-Perea, Mateo Chvatal‐Medina, Tulio J. Lopera, Natalia Álvarez Mesa, Jan Karlo Rodas-Marín, Diana Carolina Moncada, Marı́a Teresa Rugeles, Paula A. Velilla · 2022 · Frontiers in Immunology
  91. The role of the neutrophil-lymphocyte ratio in predicting poor outcomes in COVID-19 patients
    Raymond E Farah, Rola Khamisy‐Farah, Kacper Dziedzic, Ewa Skrzypek, Michał Pruc, Nicola Luigi Bragazzi, Łukasz Szarpak, Mahmoud Jomah · 2023 · Cardiology Journal
  92. Immune response to SARS-CoV-2 variants after immunization with different vaccines in Mexico
    Erika Garay, Sean P. J. Whelan, Rebecca M. DuBois, Sara M. O’Rourke, Angel Eduardo Salgado-Escobar, José Esteban Muñoz‐Medina, Carlos Federico Arias, Susana López · 2024 · Epidemiology and Infection
  93. Immunogenicity of an Inactivated COVID-19 Vaccine in People Living with HIV in Guangxi, China: A Prospective Cohort Study
    Yuting Wu, Xinwei Wang, Yunxuan Huang, Rongfeng Chen, Yuexiang Xu, Wudi Wei, Fengxiang Qin, Zongxiang Yuan, Jinming Su, Chen Xiu et al. · 2024 · Viruses
  94. Acellular Pertussis Vaccine Given in the Week After Birth Does Not Impair Antibody Responses to Later Childhood Doses
    Sonia M. McAlister, Anita H.J. van den Biggelaar, Matthew N. Cooper, Ruth B. Thornton, Peter Richmond, Helen Siobhan Marshall, Terry M. Nolan, Peter Bruce McIntyre, Nicholas J. Wood · 2025 · The Pediatric Infectious Disease Journal
  95. Anti-SARS-CoV-2 Antibodies Testing in Recipients of COVID-19 Vaccination: Why, When, and How?
    Giuseppe Lippi, Brandon Michael Henry, Mario Plebani · 2021 · Diagnostics
  96. Distinct immune response to CoronaVac in SARS-CoV-2 seropositive and seronegative patients with autoimmune rheumatic disease
    Xing-Su Gao, Feng-Cai Zhu · 2021 · The Lancet Rheumatology
  97. The benefit of boosters: diversity and inclusion in the COVID‐19 memory response
    Gemma E. Hartley, Menno C. van Zelm, Marcus J Robinson · 2021 · Immunology and Cell Biology
  98. Increased antibody response after SARS-CoV-2 mRNA-based vaccination in rituximab-treated patients with previous COVID-19 infection
    Jérôme Avouac, Roba Ghossan, Omar Al Tabaa, Alice Combier, Alexia Steelandt, M. Thomas, O. Fogel, Alice‐Andrée Mariaggi, Jean–François Méritet, Flore Rozenberg et al. · 2022 · Rheumatology
  99. Dynamics of B-Cell Responses after SARS-CoV-2 Vaccination in Spain
    Miriam San José-Cascón, Raquel de la Varga‐Martínez, Antonio Campos‐Caro, Carmen S Rodriguez · 2022 · Vaccines
  100. Healthcare Worker Study Cohort to Determine the Level and Durability of Cellular and Humoral Immune Responses after Two Doses of SARS-CoV-2 Vaccination
    Chiara Dentone, Daniela Fenoglio, Marta Ponzano, Matteo Cerchiaro, Tiziana Altosole, Diego M Franciotta, Federica Portunato, Małgorzata Mikulska, Lucia Taramasso, Laura Magnasco et al. · 2022 · Vaccines